Moderna plunges 3% as FDA warns of added risks

Monday, 30. August 2021 19:48

Shares of Moderna Inc. dropped by over 3% on Monday after the United States Food and Drug Administration (FDA) updated the company's coronavirus vaccine's fact sheet.

The FDA warned that an increased risk of pericarditis and myocarditis was observed in patients seven days after the inoculation with the vaccine's second dose. According to the FDA's fact sheet, the risk was "even higher" among "males under 40 years of age."

Moderna's shares tumbled 3.11% at 1:47 pm ET, selling for $370.5.

Related Links: 
Breaking the News / BU